Systematically initiating insulin: The staged diabetes management approach

Diabetes Educator

Volumn 32, Issue 1 SUPPL., 2006, Pages

  Pearson, Jan ^a   Powers, Margaret A ^a  

^a INTERNATIONAL DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; INSULIN;

AFTERCARE; BLOOD GLUCOSE MONITORING; CLINICAL PROTOCOL; DIABETIC DIET; DISEASE COURSE; DISEASE MANAGEMENT; DRUG ADMINISTRATION; DRUG MONITORING; DRUG SELF ADMINISTRATION; EXERCISE; GLUCOSE BLOOD LEVEL; HEALTH SERVICE; HUMAN; METABOLISM; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSING ASSESSMENT; ORGANIZATION AND MANAGEMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PATIENT SELECTION; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL SUPPORT; STANDARD;

AFTERCARE; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; CLINICAL PROTOCOLS; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; DISEASE MANAGEMENT; DISEASE PROGRESSION; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; EXERCISE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MENU PLANNING; NURSING ASSESSMENT; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION; PATIENT SELECTION; PRACTICE GUIDELINES; SELF ADMINISTRATION; SOCIAL SUPPORT;

EID: 32144451344     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721705285640     Document Type: Review

References (10)

1. Wright A, Burden AC, Paisey RB, et al. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care. 2002;25:330-336.
2. Jain R, Allen E, Wahl T, et al. Efficacy of biphasic insulin aspart 70/30 in patients with T2DM not achieving glycemic targets on OADs with/without basal insulin therapy. Diabetes. 2005;54:A69.
3. Riddle MC, Rosenstock J, Gerich JE, et al. The treat-to-target trial randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients. Diabetes Care. 2003;26:3080-3086.
4. Raskin P, Allen E, Hollander P, et al. Initiating insulin therapy in type 2 diabetes: a comparison of biphasic and basal insulin analogs. Diabetes Care. 2005;28:260-265.
5. Mazze RS, Strock E, Simonson GD, et al. Staged Diabetes Management: Prevention. Detection and Treatment of Diabetes in Adults Quick Guide. 4th ed. Minneapolis. Minnesota: Matrex; 2005.
6. Grant RW, Buse JB, Meigs, JB, et al. Quality of care in U.S. academic medical centers. Diabetes Care. 2005;28:337-442.
7. Garg SK, Gottleib PA, Hisatomi ME, et al. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine. Diabetes Res Clin Pract. 2004;66:49-56.
8. Hamann A, Matthei S, Rosak C, et al. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care. 2003;26:1738-1744.
9. Malone JK, Kerr LF, Campaigne BN, et al. Combined therapy with insulin lispro mix 75/25 plus metformin or insulin glargine plus metformin: a 16 week, randomized, open label, cross-over study in patients with type 2 diabetes beginning insulin therapy. Clin Then 2004;26:2034-2044.
10. Malone JK, Bai S, Campaigne BN, et al. Twice-daily pre-mixed insulin rather than basal insulin therapy alone results in better overall glycaemic control in patients with type 2 diabetes. Diabet Med. 2005;22:374-381.